BDSI

BioDelivery Sciences International, Inc. Press Releases

$16.62
*  
0.24
1.47%
Get BDSI Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading BDSI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
BioDelivery Sciences Announces the Hiring of J. Chris Prue as Vice President of Regulatory Affairs and Quality Assurance
10/10/2014 11:15:00 AM - PR Newswire
▲6.20 % Price Change since this news event. The Volume Ratio is 5.81.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


BioDelivery Sciences to Provide BUNAVAIL Launch Update
10/6/2014 7:49:00 PM - PR Newswire


US Patent Office Institutes Inter Partes Review Brought by MonoSol Rx Against All Claims in Key BDSI BEMA Patent
10/6/2014 9:35:00 AM - GlobeNewswire


BioDelivery Sciences to Present at the Morgan Stanley Global Healthcare Conference
9/8/2014 7:00:00 AM - PR Newswire


BioDelivery Sciences International, Inc. (NASDAQ: BDSI) to Ring The NASDAQ Stock Market Opening Bell
9/3/2014 10:00:00 AM - GlobeNewswire


BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell
9/3/2014 7:00:00 AM - PR Newswire


BioDelivery Sciences to Host Investor and Analyst Event and Webcast Friday, September 5 on BUNAVAILâ„¢ Launch and Pipeline
8/27/2014 8:00:00 AM - PR Newswire


BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA
8/12/2014 7:00:00 AM - PR Newswire


BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2014 Financials
8/7/2014 4:45:00 PM - PR Newswire


BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy
8/6/2014 7:00:00 AM - PR Newswire